The protracted and uneven recovery from the Great Recession has led most Americans to conclude that the US economy has undergone a permanent change for the worse, according to a new national study at Rutgers. Seven in 10 now say the recession’s impact is permanent, up from half in 2009 when the recession officially ended, according to the John J. Heldrich Center for Workforce Development.
Researchers from Albert Einstein College of Medicine of Yeshiva University and other institutions have developed a potential antibody therapy for Sudan ebolavirus (SUDV), one of the two most lethal strains of Ebola. A different strain, the Zaire ebolavirus (EBOV), is now devastating West Africa. First identified in 1976, SUDV has caused numerous Ebola outbreaks — most recently in 2012 — that have killed more than 400 people in total. The findings were reported in ACS Chemical Biology.
Yale University researchers have identified a handful of bacterial culprits that may drive inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis, using patients’ own intestinal immune responses as a guide.
Glass has many applications that call for different properties, such as resistance to thermal shock or to chemically harsh environments. Glassmakers commonly use additives such as boron oxide to tweak these properties by changing the atomic structure of glass. Now researchers at UC Davis have for the first time captured atoms in borosilicate glass flipping from one structure to another as it is placed under high pressure.
Source EurekAlert! Watching the structure of glass under pressure
A Mayo Clinic researcher and his collaborators have developed an online analytic tool that will speed up and enhance the process of re-engineering cells for biomedical investigation. CellNet is a free-use Internet platform that uses network biology methods to aid stem cell engineering. Details of CellNet and its application to stem cell engineering are described in two back-to-back papers in the journal Cell.
Source EurekAlert! New tool aids stem cell engineering for medical research
The Lancet: Respiratory infection controls being used for ebola patients are unnecessary and may contribute to public panic
Respiratory infection control measures — which have been adopted by most health agencies to deal with the Ebola epidemic in west Africa — are unnecessary, and may heighten panic and fear among the public, according to the authors of a new letter, published in The Lancet, and written by professor Jose M. Martin-Moreno from the University of Valencia in Spain, and colleagues.
A unique method for delivering compounds that could positively impact the global battle against HIV and AIDS may be possible, thanks to researchers in Penn State’s College of Agricultural Sciences.
Source EurekAlert! Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS